Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–49.

Article  Google Scholar 

Kumar A, Sharipov M, Turaev A, Azizov S, Azizov I, Makhado E, Pandey S. Polymer-based hybrid nanoarchitectures for cancer therapy applications. Polymers. 2022;14(15):3027.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Asamura H, Goldstraw P. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2014;9(11):1618–24.

Article  PubMed  CAS  Google Scholar 

Chansky K, Detterbeck FC, Nicholson AG, Rusch VW, Vallières E, Groome P, Yokoi K. The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition the TNM classification of lung cancer. J Thorac Oncol. 2017;12(7):1109–21.

Article  PubMed  Google Scholar 

Wahbah M, Boroumand N, Castro C, El-Zeky F, Eltorky M. Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases. Ann Diagn Pathol. 2007;11(2):89–96.

Article  PubMed  Google Scholar 

Travis WD, Brambilla E, Riely GJ. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol. 2013;31(8):992–1001.

Article  PubMed  CAS  Google Scholar 

Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584–94.

Article  PubMed  Google Scholar 

Brambilla C, Laffaire J, Lantuejoul S, Moro-Sibilot D, Mignotte H, Arbib F, Brambilla E. Lung squamous cell carcinomas with basaloid histology represent a specific molecular entity. Clin Cancer Res. 2014;20(22):5777–86.

Article  PubMed  CAS  Google Scholar 

Mukhopadhyay S, Katzenstein ALA. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol. 2011;35(1):15–25.

Article  PubMed  Google Scholar 

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Modern Pathol. 2011;24(10):1348–59.

Article  Google Scholar 

Tacha D, Yu C, Bremer R, Qi W, Haas T. A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma. Appl Immunohistochem Mol Morphol. 2012;20(3):201–7.

Article  PubMed  CAS  Google Scholar 

Jain D, Roy-Chowdhuri S. Molecular pathology of lung cancer cytology specimens: a concise review. Archiv Pathol Lab Med. 2018;142(9):1127–33.

Article  CAS  Google Scholar 

Villalobos P, Wistuba II. Lung cancer biomarkers. Hematol Oncol Clin. 2017;31(1):13–29.

Article  Google Scholar 

Iams WT, Porter J, Horn L. Immunotherapeutic approaches for small-cell lung cancer. Nat Rev Clin Oncol. 2020;17(5):300–12.

Article  PubMed  PubMed Central  Google Scholar 

Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–54.

Article  PubMed  CAS  Google Scholar 

Cragg GM, Newman DJ, Yang SS. Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience. J Nat Prod. 2006;69(3):488–98.

Article  PubMed  CAS  Google Scholar 

Hanna N, Johnson D, Temin S, Baker S Jr, Brahmer J, Ellis PM, Masters G. Systemic therapy for stage IV non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(30):3484–515.

Article  PubMed  CAS  Google Scholar 

Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168(4):707–23.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sharma S, Shukla MK, Sharma KC, Tirath K, L., Anal, J. M. H., … & Kumar, D. Revisiting the therapeutic potential of gingerols against different pharmacological activities. Naunyn-Schmiedeberg’s Arch Pharmacol. 2023;396(4):633–47.

Article  CAS  Google Scholar 

Sharma A, Nagraik R, Sharma S, Sharma G, Pandey S, Azizov S, Kumar D. Green synthesis of ZnO nanoparticles using Ficus palmata: antioxidant, antibacterial and antidiabetic studies. Results Chem. 2022;4:100509.

Article  CAS  Google Scholar 

Hara H, Williams LHJ, Whitmore TC, Sutton SY, Chater AO (1979) An enumeration of the flowering plants of Nepal; a joint project of the British Museum (Natural History) and the Univ. of Tokyo-v. 2:(Angiospermae (Dicotyledones)).

Joshi RK, Satyal P, Setzer WN. Himalayan aromatic medicinal plants: a review of their ethnopharmacology, volatile phytochemistry, and biological activities. Medicines. 2016;3(1):6.

Article  PubMed  PubMed Central  Google Scholar 

Singh DK, Hajara PK. Changing perspectives of biodiversity status in the Himalaya. New Delhi: British Council Division; 1996. p. 23–38.

Google Scholar 

Verpoorte R. Pharmacognosy in the new millennium: leadfinding and biotechnology. J Pharm Pharmacol. 2000;52(3):253–62.

Article  PubMed  CAS  Google Scholar 

Alharbi KS, Almalki WH, Makeen HA, Albratty M, Meraya AM, Nagraik R, Gupta G. Role of Medicinal plant-derived Nutraceuticals as a potential target for the treatment of breast cancer. J Food Biochem. 2022;46(12):e14387.

Article  PubMed  CAS  Google Scholar 

Shukla MK, Thakur A, Verma R, Lalhlenmawia H, Bhattacharyya S, Bisht D, Kumar D. Unravelling the therapeutic potential of orchid plant against cancer. South Afr J Bot. 2022;150:69–79.

Article  CAS  Google Scholar 

Heo BG, Park YJ, Park YS, Bae JH, Cho JY, Park K, Gorinstein S. Anticancer and antioxidant effects of extracts from different parts of indigo plant. Ind Crops Prod. 2014;56:9–16.

Article  CAS  Google Scholar 

Wen L, Wu D, Jiang Y, Prasad KN, Lin S, Jiang G, Yang B. Identification of flavonoids in litchi (Litchi chinensis Sonn.) leaf and evaluation of anticancer activities. J Funct Foods. 2014;6:555–63.

Article  CAS  Google Scholar 

Wen T, Song L, Hua S. Perspectives and controversies regarding the use of natural products for the treatment of lung cancer. Cancer Med. 2021;10(7):2396–422.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Dive C. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol. 2012;30(5):525–32.

Article  PubMed  Google Scholar 

Karam I, Jiang SY, Khaira M, Lee CW, Schellenberg D. Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide. Am J Clin Oncol. 2015;38(1):51–4.

Article  PubMed  CAS  Google Scholar 

Wakeam E, Acuna SA, Leighl NB, Giuliani ME, Finlayson SRG, Varghese TK, Darling GE. Surgery versus chemotherapy and radiotherapy for early and locally advanced small cell lung cancer: a propensity-matched analysis of survival. Lung Cancer. 2017;109:78–88.

Article  PubMed  CAS  Google Scholar 

Pignon JP, Auperin A, Borget I, Hill C. Role of meta-analyses and of large randomized trials in the study of cancer treatments. Lung Cancer. 2009;65(1):9–12.

Article  PubMed  Google Scholar 

Lawrence TS, Rosenberg SA, DePinho RA, R.A. Cancer: Principles & Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2011.

Google Scholar 

Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Wojtukiewicz M. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. The Lancet. 2019;394(10212):1929–39.

Article  CAS  Google Scholar 

Rudin CM, Awad MM, Navarro A, Gottfried M, Peters S, Csőszi T. Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study. J Clin Oncol. 2020;38(21):2369.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sauter ER. Cancer prevention and treatment using combination therapy with natural compounds. Expert Rev Clin Pharmacol. 2020;13(3):265–85.

Article  PubMed  CAS  Google Scholar 

Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–95.

Article  PubMed  CAS  Google Scholar 

Nagase H, Visse R, Murphy G. Structure and function of matrix